Your Messages Inbox
Your Article Summary
See Latest ArticlesGSK and Enigma Diagnostics Announce Commercial Partnership to Develop Point-of-Care Influenza Diagnostics
GlaxoSmithKline, 07/22/09
GlaxoSmithKline (GSK) and Enigma Diagnostics Limited announced that they have signed worldwide agreements to develop and supply the first point–of–care diagnostic influenza tests to identify specific influenza virus strains using its real–time Polymerase Chain Reaction (PCR) technology platform, the Enigma ML (Mini Laboratory).
Related Articles
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
British Journal of Cancer, 11/20/09
Relevance Score: 43%
Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
American Journal of Psychiatry, 11/20/09
Relevance Score: 43%
GSK partners with UK Government and Wellcome Trust to stimulate innovation through the creation of a world-class science park
GlaxoSmithKline, 10/14/09
Relevance Score: 43%
Pandemic (H1N1) 2009 Influenza Update: Experience of GSK's H1N1 adjuvanted vaccine, Pandemrix, and preliminary paediatric results
GlaxoSmithKline, 10/26/09
Relevance Score: 42%
GSK expands presence in China through strategic cooperation to form a joint venture on paediatric vaccines
GlaxoSmithKline, 10/07/09
Relevance Score: 42%
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Watson Receives FTC Clearance for Arrow Acquisition
Watson Pharmaceuticals, 12/03/09
Watson Completes Acquisition of Arrow Group
Watson Pharmaceuticals, 12/03/09
GSK completes extension of strategic collaboration with Aspen
GlaxoSmithKline, 12/02/09
Article Search
Sponsor